Tags: US | Sanofi | Deal | Talks

Shares Jump for Potential Targets of Sanofi Deal

Rumors French pharmaceutical giant Sanofi-Aventis SA is chasing a big U.S. acquisition have driven up shares of companies investors think might be a target.

Shares of Allergan Inc. jumped as much as 9 percent, while Genzyme Corp. and Biogen Idec Inc. both were up at least 5 percent.

That's after a report by Bloomberg indicated that Sanofi Chief Executive Chris Viehbacher this week briefed his board at a special meeting, saying that the company is working on a deal for a major acquisition in the U.S.

The report says the deal is in the very early stages and does not identify the American company.

A Sanofi spokesman in the U.S. says the company does not comment on market rumors.

© Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1Like our page
2Share
InvestingAnalysis
Rumors French pharmaceutical giant Sanofi-Aventis SA is chasing a big U.S. acquisition have driven up shares of companies investors think might be a target.Shares of Allergan Inc. jumped as much as 9 percent, while Genzyme Corp. and Biogen Idec Inc. both were up at least 5...
US,Sanofi,Deal,Talks
119
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved